日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities

用于治疗实体瘤的T细胞衔接抗体:挑战与机遇

Baeuerle, Patrick A; Wesche, Holger

IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal)

IRAK1 和 IRAK4 促进 MyD88 衔接蛋白样蛋白 (Mal) 的磷酸化、泛素化和降解

Dunne, Aisling; Carpenter, Susan; Brikos, Constantinos; Gray, Pearl; Strelow, Astrid; Wesche, Holger; Morrice, Nick; O'Neill, Luke A J

The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo.

生长因子 Midkine 在体外和体内均能拮抗 VEGF 信号传导

van der Horst Edward Htun, Frank Brendon T, Chinn Lawrence, Coxon Angela, Li Shyun, Polesso Fanny, Slavin Anthony, Ruefli-Brasse Astrid, Wesche Holger